Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Camelot BioCapital
United Statescamelotbiocapital.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Camelot BioCapital is a biotech venture studio that partners with inventors and academic institutions to create and advance novel therapeutics. The leadership team has raised over $2 billion in capital historically, advanced more than 20 drug candidates into human clinical trials, achieved 7 FDA approvals across their collective experience, and focuses on de-risking early-stage biotech investments. Their current portfolio has collectively raised over $100 million for R&D targeting cancer and other life-threatening conditions. Specific clinical results for individual programs are not disclosed.
- Therapeutic areas
- OncologyRare DiseasesImmunologyNeurology
- Modalities
- Small moleculeBiologicMonoclonal antibody
- Industry
- Investors
02
Partnerships
Massachusetts Institute of Technology (MIT)Mayo ClinicMemorial Sloan Kettering Cancer CenterMD Anderson Cancer CenterWashington University at St. LouisUniversity of New MexicoRutgers UniversityNIH/NCIVeterans Health AdministrationUniversity of MiamiMoffitt Cancer CenterUniversity of FloridaRoswell Park Cancer InstituteHebrew UniversityUniversity of San FranciscoUniversity of PennsylvaniaJohns Hopkins UniversityWeizmann InstituteUniversity of AlabamaPittsburgh UniversityPrinceton University
Beyond the preview
Go deeper on Camelot BioCapital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Camelot BioCapital.